Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.

CONTEXT Nonpharmacologic interventions are frequently recommended for treatment of hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials in support of this recommendation. OBJECTIVE To determine whether weight loss or reduced sodium intake is effective in the treatment of older persons with hypertension. DESIGN Randomized controlled trial. PARTICIPANTS A total of 975 [corrected] men and women aged 60 to 80 years with systolic blood pressure lower than 145 mm Hg and diastolic blood pressure lower than 85 mm Hg while receiving treatment with a single antihypertensive medication. SETTING Four academic health centers. INTERVENTION The 585 obese participants were randomized to reduced sodium intake, weight loss, both, or usual care, and the 390 nonobese participants were randomized to reduced sodium intake or usual care. Withdrawal of antihypertensive medication was attempted after 3 months of intervention. MAIN OUTCOME MEASURE Diagnosis of high blood pressure at 1 or more follow-up visits, or treatment with antihypertensive medication, or a cardiovascular event during follow-up (range, 15-36 months; median, 29 months). RESULTS The combined outcome measure was less frequent among those assigned vs not assigned to reduced sodium intake (relative hazard ratio, 0.69; 95% confidence interval [CI], 0.59-0.81; P<.001) and, in obese participants, among those assigned vs not assigned to weight loss (relative hazard ratio, 0.70; 95% CI, 0.57-0.87; P<.001). Relative to usual care, hazard ratios among the obese participants were 0.60 (95% CI, 0.45-0.80; P<.001) for reduced sodium intake alone, 0.64 (95% CI, 0.49-0.85; P=.002) for weight loss alone, and 0.47 (95% CI, 0.35-0.64; P<.001) for reduced sodium intake and weight loss combined. The frequency of cardiovascular events during follow-up was similar in each of the 6 treatment groups. CONCLUSION Reduced sodium intake and weight loss constitute a feasible, effective, and safe nonpharmacologic therapy of hypertension in older persons.

[1]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[2]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[3]  Alan C. Wilson,et al.  Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE) , 1997, Journal of the American Geriatrics Society.

[4]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[5]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[6]  P. Elliott,et al.  Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations , 1996 .

[7]  I. Puddey,et al.  Exercise lowers blood pressure--sometimes? Or did Pheidippides have hypertension? , 1995, Journal of hypertension.

[8]  D. Kerr,et al.  A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. , 1995, The American journal of clinical nutrition.

[9]  T. Raghunathan,et al.  The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.

[10]  P. Whelton,et al.  The contribution of urinary cations to the blood pressure differences associated with migration. , 1995, American journal of epidemiology.

[11]  N. Cook,et al.  An unexpected result for sodium--causal or casual? , 1995, Hypertension.

[12]  J. Laragh,et al.  Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. , 1995, Hypertension.

[13]  P. Whelton,et al.  Trends in pharmacologic management of hypertension in the United States. , 1995, Archives of internal medicine.

[14]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[15]  Alan C. Wilson,et al.  Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. , 1995, Annals of epidemiology.

[16]  T. Chard.  Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. , 1994, Growth regulation.

[17]  Lippincott Williams Wilkins,et al.  National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly , 1994, Hypertension.

[18]  P. Whelton,et al.  Body mass and blood pressure in a lean population in southwestern China. , 1994, American journal of epidemiology.

[19]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[20]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[21]  Jessica A. Mayer,et al.  Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. , 1993, Archives of internal medicine.

[22]  A. Rodgers,et al.  The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. , 1993, Clinical and experimental hypertension.

[23]  W. Cushman,et al.  Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. , 1992, Archives of internal medicine.

[24]  N. Cook,et al.  The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .

[25]  Craig K. Ewart.  Social action theory for a public health psychology. , 1991, The American psychologist.

[26]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[27]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[28]  S. Kumanyika.  Weight reduction and sodium restriction in the management of hypertension. , 1989, Clinics in geriatric medicine.

[29]  D Feskanich,et al.  Computerized collection and analysis of dietary intake information. , 1989, Computer methods and programs in biomedicine.

[30]  J. Cutler,et al.  Obesity and hypertension: epidemiological and clinical issues. , 1987, European heart journal.

[31]  A. Dyer,et al.  Nutritional Therapy for High Blood Pressure: Final Report of a Four-Year Randomized Controlled Trial— The Hypertension Control Program , 1987 .

[32]  R. Baxter,et al.  Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.

[33]  D. Powell,et al.  Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. , 1986, The Journal of clinical endocrinology and metabolism.

[34]  N. Rychlik,et al.  Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. , 1986, Journal of immunological methods.

[35]  S. MacMahon,et al.  The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. , 1986, The New England journal of medicine.

[36]  G. Andrews,et al.  COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS , 1985, The Lancet.

[37]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[38]  R. Newcombe,et al.  Effects of maternal smoking on fetal growth and nutrition. , 1981, Archives of disease in childhood.

[39]  J. Garrow,et al.  Random-zero sphygmomanometer. , 1970, Lancet.

[40]  Samuel Meites,et al.  Standard Methods of Clinical Chemistry , 1970 .

[41]  Rose Ga.  ISCHEMIC HEART DISEASE. CHEST PAIN QUESTIONNAIRE. , 1965 .

[42]  G. A. Rose.  ISCHEMIC HEART DISEASE. CHEST PAIN QUESTIONNAIRE. , 1965, The Milbank Memorial Fund quarterly.